NVAX (novavax.com) יחס שווי פעילות להכנסות

לוגו של חברה ציבורית Novavax Inc (NVAX)

Complex cold chain logistics increase delivery costs for Novavax, Inc. (NVAX), creating volatility as reflected in the EV/Sales multiple chart. The latest value is recorded as 2299.94. Stability is provided by a strategy to transition toward commercial protein vaccines supported by a global alliance. Simultaneously, Novavax, Inc. (NVAX) is optimizing costs by switching contract manufacturers and implementing a seamless outsourcing management model.

NVAX שווי חברה להכנסות Novavax Pharma (23.11.2025 - 20.11.2026)

פילוחי מדדים פיננסיים ומדדי שוק עבור Novavax, Inc. (NVAX)

- מחיר ותחזית קונצנזוס למחירים:
- מדדי הערכת שווי שוק של העסק:
הערכת שווי פונדמנטלית:Novavax, Inc. NVAX
מוצר סדרתי של Novavax Pharma

Novavax, Inc. (NVAX) is transforming its business model, shifting from COVID-19 products toward combination vaccines and licensing. By analyzing the enterprise value-to-annual revenue multiple, an investor assesses the market value of the business excluding debt load. This chart reflects the efficiency of operational growth relative to capitalization. A decline in this metric confirms the fundamental strengthening of the company's position, allowing analysts to strip away share price volatility when valuing real assets.